Table 1.

Sociodemographic and Clinical Characteristics of the Study Sample (n = 146)

Characteristic	Frequency (%) or mean (SD)	Median (IQ 25–75)
Sex
Male/female	78 (53.4%)/68 (46.6%)
Hospitalized
Yes/no	64 (43.8%)/82 (56.2%)
Education (years)	6.81 (4.17)	6 (0; 17)
	65.16 (14.04)	66 (58; 75)
Karnofsky performance status scale (KPS)	59.18 (21.38)	50 (40; 80)
Score ≤ 60/score > 61	42.77 (10.74)/80.79 (9.03)	50 (20; 60)/80 (70; 100)
Score NPS (0–10), most of the time in the last 24 h
Cancer (yes/no)	4.4 (3.61)/4.74 (3.99)	5 (0; 10)/6 (0; 10)
Score on NPS (0–10) after use pain medication
Cancer (yes/no)	2 (2.83)/2.21 (2.69)	0 (0; 10)/0 (0; 8)

Primary cancer clinical diagnosis	Frequency (%)
Palliative care patients without cancer	44 (30)
Lung carcinoma	15 (10)
Head and neck cancer	15 (10)
Melanoma	4 (3)
Breast cancer	9 (6)
Adenocarcinoma	6 (4)
Esophagus cancer	9 (6)
Prostate carcinoma	13 (9)
Bowel cancer	1 (1)
Colorectal cancer	5 (3)
Stomach cancer	7 (5)
Lymphoma	1 (1)
Hepatoma	2 (1)
Endometrial cancer	4 (3)
Kidney cancer	2 (1)
Bladder cancer	2 (1)
Diagnosis to be confirmed	7 (5)